Evidence map›Paper›PMID 37284808›Full record

ReviewMinerva pediatrics2024

Effects of dietary sugar restriction on hepatic fat in youth with obesity.

Johanna K Distefano, Glenn S Gerhard

Open access · greenAbstract readReview
In one paragraph

Review in Minerva pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Johanna K DistefanoMetabolic Disease Research Unit, Translational Genomics Research Institute, Phoenix, AZ, USA - jdistefano@tgen.org.
Glenn S GerhardLewis Katz School of Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
Temple University · USTranslational Genomics Research Institute · US

Funding

Extracellular vesicle cargo and risk of NAFLD and NASH in U.S. youthR01DK127015 · NIDDK · TRANSLATIONAL GENOMICS RESEARCH INST · PI Johanna K DiStefano, Gabriel Quantum Shaibi · 2022 to 2026
$3.9M
Profiling extracellular vesicle cargo in obesity and type 2 diabetesR01DK120890 · NIDDK · TRANSLATIONAL GENOMICS RESEARCH INST · PI DISTEFANO, JOHANNA K, GERHARD, GLENN S · 2019 to 2024
$3.7M
NIDDK NIH HHS R01 DK120890NIDDK NIH HHS R01 DK127015
6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in children. Like adults, children can develop the progressive form of NAFLD, nonalcoholic steatohepatitis (NASH), which is characterized by hepatic inflammation, often in the presence of fibrosis. Children with NAFLD are at higher risk of liver-related complications, metabolic dysfunction, and cardiovascular disease in adulthood. Many factors contribute to the escalating prevalence of NAFLD in the pediatric population, among which are an array of dietary patterns such as overnutrition, poor diet quality, and heavy consumption of fat and sugar, including fructose. Findings from an increasing number of epidemiological studies support a connection between high habitual sugar consumption and NAFLD, especially within the context of obesity, but these studies are not able to demonstrate whether sugar is a contributing factor or instead an indicator of an overall poor diet (or lifestyle) quality. To date, only four randomized controlled dietary interventions assessing the effects of sucrose/fructose restriction on hepatic fat fraction in youth with obesity have been published. The objectives of this review are to summarize the key findings from these dietary interventions to achieve a better understanding of the strength of the relationship between dietary sugar restriction and liver fat reduction, despite their inherent limitations, and to discuss the potential impact of weight loss and fat mass reduction on improvement in hepatic steatosis.

Indexed as

Dietary SugarsNon-alcoholic Fatty Liver DiseasePediatric ObesityAdolescentChildFructoseHumansLiverRandomized Controlled Trials as TopicDietary SugarsFructose

Identifiers

PMID37284808
PMCPMC11229704
OpenAlexW4379600912

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.